Stay updated on Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T19:36:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed information about a phase II trial for cabozantinib in treating osteosarcoma and Ewing sarcoma, while adding new identifiers and classifications related to these conditions.
    Difference
    52%
    Check dated 2025-04-16T14:25:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T09:17:03.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has been updated to include information on Soft Tissue Sarcoma while removing references to Osteosarcoma. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:23:19.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T13:58:58.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T21:13:23.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Relapsed Osteosarcoma/Ewing Sarcoma Clinical Trial page.